Affordable World-class Treatment - Accredited Hospitals - Free Treatment Plan in 24 Hrs
Share your details to receive a personalised treatment plan, estimated costs, hospital recommendations, and expert guidance, “completely free.”
Your information is protected with HIPAA-compliant security standards. We only share your details with hospitals after your consent.
The cost of CAR-T in Singapore is USD 475000
Additionally, factors like the duration of treatment, the need for follow-up care, and the use of advanced technologies or specialized treatments can further influence the overall cost.
CART is an acronym for a promising experimental type of cancer treatment called Chimeric Antigen Receptor T-cell therapy and mainly targets blood malignancies such as leukemia and lymphoma. This therapy is done by modifying the patient’s T-cells (one form of white blood cells) in the laboratory and making them have a receptor that homes in on cancerous cells. These engineered T-cells are then transduced back into the patient, they go on to hunt for cancer cells to kill.
CART therapy is rather effective, particularly in the cases of the treatment efficacy of which has not been rather impressive. It is individual treatment, which means that is independent of the cancer type in the patient. There are risks for cytokine release syndrome (CRS), as well as neurotoxicity that should be closely watched out for, but this option is hopeful for cancer patients who normally cannot be treated with conventional treatments.
| City | Cost (USD) | |
|---|---|---|
| Singapore | $475,000 | Explore More |
Alvina Hasan is a dedicated medical researcher and scientific writer with a strong foundation in pharmaceutical sciences. She holds a B.Pharm from Jamia Hamdard University and an M.Pharm in Quality Assurance from DIPSAR University.
With deep medical expertise and a strong interest in healthcare communication, she focuses on transforming complex clinical and scientific information into clear, engaging, and easy-to-understand narratives. She develops insightful healthcare articles and research-driven content designed to support both medical professionals and patients, helping bridge the gap between advanced medical knowledge and practical understanding.
Readers can explore her published research and articles here:
Our dedicated Medical Patient Advisors are here to answer your questions, help you compare treatment options, estimate costs, and guide you through every step of your healthcare journey.
CAR T-cell therapy represents a groundbreaking approach to harnessing the power of the body's immune system to combat cancer. By modifying T cells, a subset of white blood cells, in a laboratory setting, these cells are empowered to recognize and eliminate cancer cells with precision. Often categorized as a form of cell-based gene therapy, CAR T-cell therapy involves altering the genetic makeup of T cells, equipping them with the ability to target specific cancer antigens.
This innovative treatment has demonstrated remarkable efficacy, particularly in cases where conventional therapies have proven ineffective. Its ability to reprogram the immune system to target and destroy cancer cells marks a significant advancement in cancer treatment strategies.
CAR T cell therapy is classified as follows:
Antigen-based classification: It includes
CAR T-cell therapy is primarily used to treat blood cancers, such as multiple myeloma, large B-cell lymphoma, and B-cell acute lymphoblastic leukaemia. The patient's own T cells are reprogrammed to identify and destroy cancer cells, cause remission, enhance survival, and have a plan B in case other treatments fail.
Patients with blood cancers who relapsed or are refractory must consult an oncologist to determine candidacy for CAR T therapy, especially if they have failed to respond to traditional treatments (i.e., chemotherapy, radiation, or stem cell transplant). Evaluation is warranted for symptoms such as loss of weight, swelling of lymph nodes, recurrent infection, chronic fatigue, or spontaneous bruising.
Screening tests consist of imaging, bone marrow biopsy, and blood work.
Leukapheresis is utilised to harvest T cells from the patient's blood for T-cell collection.
Bridging therapy: Certain patients receive chemotherapy while waiting for CAR T cells to be produced.
Lymphodepleting chemotherapy is administered before the injection to make room for CAR T cells. The patients should plan for potential hospitalisation, designate caretakers, and discuss long-term follow-up and expected adverse effects with the medical team.
The whole process, from cell harvesting to infusion, can take three to six weeks. The infusion itself takes a few hours to a few minutes, but for at least one week following the infusion, close monitoring is required, and there will be frequent follow-ups for several months.
One of the newer treatment options for some blood cancers is CAR T-cell therapy. It is utilised when other treatments are not working or the cancer recurs. CAR T-cell therapy has the potential to cure many blood cancers and extend life in most cases.
Recovery involves managing side effects like CRS and neurotoxicity, monitoring blood levels, and avoiding infections. Laboratory testing, imaging, and monitoring for late issues like hypogammaglobulinemia or relapse are all included in long-term follow-up.
The nature of the cancer, the burden of the disease, and an individual's response all impact success. For example, in pediatric acute lymphoblastic leukaemia, complete remission rates are more than 80%. However, relapse is always a risk, and long-term success is variable.
80%
Complete remission (pediatric ALL)2 days
in hospital post-infusion3 Months
to typical return to workOur experienced Medical Patient Advisors have supported 100,000+ patients across 120+ countries with personalised treatment plans, hospital recommendations, cost estimates, and travel assistance, all free.
✓ Free Consultation ✓ No Obligation ✓ Personalized Treatment Plan ✓ Response Within 24 Hours
Your medical info is kept HIPAA-style confidential. We never share with hospitals without your consent.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Hendrik decided to come to India for his treatment after a thorough discussion with MediGence. India is known for its…
A. Many hospitals in Singapore perform CAR-T. The top hospitals for CAR-T in Singapore include the following:
A. The patient's recovery may differ based on several factors. After being discharged, a patient is expected to remain in the country for approximately thirty days on average, but this can vary depending on the patient's health condition. The patient has evaluations and consultations during this period. This ensures the patient is safe to return and that the treatment was successful.
A. In addition to the CAR-T therapy cost, patients may have to pay additional daily charges for services such as meals and other facilities during their stay. The extra charges may start from USD 150 per person.
A. The following are some of the best cities for CAR-T in Singapore:
A. After a CAR-T, patients typically stay in the hospital for two or more days, depending on their condition, to receive the necessary care and monitoring. The patient is closely watched during recovery, and control tests are run to ensure everything is in order. Physiotherapy sessions are also scheduled during hospital recovery if necessary.
A. Hospitals in Singapore offering CAR-T therapy are highly regarded for their advanced medical facilities and exceptional patient care. The rating is usually based on different parameters such as the attitude of the nurses, cleanliness, quality of food, comfort of hospital rooms, and pricing policy, as CAR-T therapy can be expensive.
A. Some of the best doctors for CAR-T in Singapore are:
A. The type of cancer being treated is one of the factors that can affect the success rate of CAR-T (Chimeric Antigen Receptor T-cell) treatment.
For relapsed or refractory B-cell lymphoma, the long-term success rate of CAR T-cell therapy in Singapore is between 30–40%. The success rate for B-cell Acute Lymphoblastic Leukemia (ALL) that has relapsed or is refractory is greater than 50%.
CAR T-cell therapy has demonstrated encouraging outcomes in treating lymphoma and blood tumours. It can offer a better survival advantage than conventional chemotherapy, especially for relapsed or refractory blood cancers.
A. After receiving an infusion, patients may stay in the hospital for up to two weeks, and they should prepare for a two to three-month risk and recovery. Patients are assessed for side effects and therapy response during this period. Stays in hospitals to treat problems are common during this time. During the first 30 days following CAR T-cell infusion, patients must stay close to the medical facility for routine follow-up care.
A. Yes, several pre-operative tests and evaluations are necessary to determine your eligibility and ensure you are in the best possible condition for CAR-T (Chimeric Antigen Receptor T-cell) therapy.
A. Whether CAR-T (Chimeric Antigen Receptor T-cell) therapy is right for you depends on several factors related to your medical condition, overall health, and response to previous treatments. Here are some factors to consider when determining if CAR-T therapy is appropriate for you:
A. Chimeric Antigen Receptor T-cell (CAR-T) therapy can have several risks and complications, including:
Additional side effects consist of:
A. Several variables, such as your general health, how well you tolerate the treatment, and any possible side effects, might affect how long you stay in the hospital following CAR-T (Chimeric Antigen Receptor T-cell) therapy. In Singapore, the average length of hospitalisation following CAR-T therapy is two to four weeks.
Here's what to expect:
A. It may take a few weeks or months to recover from CAR T-cell therapy, and you should expect to have follow-up appointments to check in with your medical team. Here are a few pointers to look upon following the treatment:
During the healing process, you must prepare for feeling weak, exhausted, and lost appetite. Additionally, you could struggle with memory, focus, confusion, planning, or staying organised.
You will be continuously watched for neurological abnormalities, fever, and infection symptoms. If these symptoms appear, the medical care team will assist.
Follow-up consultations with the medical team will be needed.
The body will need a little time to heal properly before returning to regular activities.
It may take several months for fatigue to get better. You must listen to your body, pace yourself accordingly, and divide everyday tasks into small phases.
During treatment, your strength and level of fitness may decrease. You can ask for assistance from a physiotherapist to build up your strength or to return to exercise.
Have your reports reviewed by independent oncology experts to help you make a confident treatment decision, all online within 48 hours.
Upload Your Reports
